Content:
Overview
Content on this page:
Overview
Content on this page:
Overview
Overview
Pityriasis (Tinea) versicolor is a fungal infection caused by Malassezia furfur. It is benign, superficial, and localized to the stratum corneum.
It occurs most commonly in postpubertal individuals when the sebaceous glands are the most active.
Facial involvement is common in adolescents, but lesions are also found on the upper trunk, neck, arms, dorsum of the hand and pubis.
Patient presents with erythematous, hypo- or hyperpigmented macules or patches that may have a slight scale.
Treatment is usually effective but may have to be repeated due to recurrence of infection in susceptible individuals. Prophylactic treatment is recommended for patients at risk of recurrence on exposure to sunlight or warm humid conditions. Skin discoloration may take several weeks to resolve after complete treatment If mycology is negative, persisting pale patches do not necessarily warrant additional treatment.
Topical agents can be very effective and are safer than systemic medications, especially in children.
For further information regarding the management of Pityriasis (Tinea) Versicolor (Pediatric), please refer to Disease Algorithm for the Treatment Guideline.
It occurs most commonly in postpubertal individuals when the sebaceous glands are the most active.
Facial involvement is common in adolescents, but lesions are also found on the upper trunk, neck, arms, dorsum of the hand and pubis.
Patient presents with erythematous, hypo- or hyperpigmented macules or patches that may have a slight scale.
Treatment is usually effective but may have to be repeated due to recurrence of infection in susceptible individuals. Prophylactic treatment is recommended for patients at risk of recurrence on exposure to sunlight or warm humid conditions. Skin discoloration may take several weeks to resolve after complete treatment If mycology is negative, persisting pale patches do not necessarily warrant additional treatment.
Topical agents can be very effective and are safer than systemic medications, especially in children.
For further information regarding the management of Pityriasis (Tinea) Versicolor (Pediatric), please refer to Disease Algorithm for the Treatment Guideline.